Mensa Guide

Name: Mensa Guide revenue & download estimates
Creator: AppCurrents

App Store·MedicalFree + IAP★ 0.00 (0)launched 7.3y agoapp updated 4d agocharts in 3 countries

Scout Score

Mensa Guide generates an estimated $0/month in revenue from 0 downloads/month on the App Store, according to AppCurrents estimates (updated 2026-06-17).

Estimates updated 17.06.2026 · How we estimate · Ranges reflect model confidence, not exact figures.
Est. revenue / month	$0
Est. downloads / month	0
Estimate confidence	low
Pricing	Free + IAP
Rating	0.00 ★ (0 ratings)
Category	Medical
Released	02.03.2019
App last updated	13.06.2026
Platform	iOS

Est. downloads / mo

Est. revenue / mo

Rating velocity / day

Chart velocity

—

Peak rank

—

Days tracked

—

Modeled monthly estimate · rating velocity · low confidence

About

Mensa Guide is a comprehensive antimicrobial reference designed to support optimal therapeutic decision-making in infectious diseases. Content is structured for rapid access to key information, while allowing seamless exploration of additional details through inline notes. • Tap on any word in the text to navigate to another entry, check abbreviations, view explanatory notes, open clinical calcul…

View on the App Store → Android version →

Trends & analysis

Chart rank trend

US · overall

Collecting rank history — no snapshots so far. Fills in twice daily.

Why it's surfacing

Scout 4

Newness

Breakout

Ratings & velocity

★ 0 in window

Total ratings

Jun 4Jun 17

New ratings / day

Jun 5Jun 17

Geographic reach

best rank · 3 storefronts

#46 category

#92 category

#95 category

Revenue & downloads trend

monthly estimate

Est. revenue / mo · $0

Jun 4Jun 17

Est. downloads / mo · 0

Jun 4Jun 17

In-app purchases

2 tiers

Monthly Subscription$2

Annual Subscription$20

Update history

3 updates tracked

v26.244d ago
• Added bepirovirsen and cefepime/zidebactam to Antimicrobials. • Changes in fosmanogepix, ibrexafungerp, maribavir, olorofim, and ECOFF values (aztreonam/avibactam). Sphingomonas, Stenotrophomonas; Aspergillus, Candida; CMV, Ebola, EBV, HBV, MPXV; Plasmodium falciparum. Infections in patients with liver cirrhosis. Pneumonia. Prosthetic joint infection. Asymptomatic bacteriuria (UTI prevention). RSV vaccination. Venous catheter infection (prevention).
v26.2311d ago
• Added a PaO₂ estimation calculator (from SpO₂). • Changes in cefiderocol, ceftriaxone, dalbavancin, eravacycline, isoniazid, tigecycline. Enterococcus, Mycobacterium tuberculosis, Pneumocystis jirovecii; CMV, SARS-CoV-2; Babesia. Prosthetic joint infection. Viral hemorrhagic fevers. CMV prophylaxis. HPV vaccination. RSV vaccination. Shingles (herpes zoster) vaccination. Surgical site infection prophylaxis. Toxoplasma gondii (prevention in hematologic patients).
v26.2218d ago
• Added a new entry on infections in patients with major burns (under Syndromes). • Changes in bictegravir, cabotegravir, cefiderocol, ensitrelvir, ertapenem, nitrofurantoin, pristinamycin, zoliflodacin. Chlamydia psittaci, Mycobacterium xenopi, Mycoplasma genitalium, Neisseria gonorrhoeae, Pseudomonas aeruginosa; Diutina, Purpureocillium; CMV, JCPyV, KFDV, RSV, SARS-CoV-2; Echinococcus granulosus, Leishmania. Biomarkers of inflammation/infection. Infections during CAR T-cell therapy. Pneumonia. CMV prophylaxis. RSV prevention. RSV vaccination. Tuberculosis prevention.